Mesothelioma treatment options in adults
Mesothelioma is a rare and aggressive cancer primarily caused by exposure to asbestos fibers. It affects the lining of the lungs (pleural mesothelioma), abdomen (peritoneal mesothelioma), or, less commonly, the heart. Due to its aggressive nature and late diagnosis, treatment options for adults with mesothelioma are often complex and require a multidisciplinary approach. Advances in medical research have provided a range of options aimed at extending survival, alleviating symptoms, and improving quality of life.
Surgical interventions are a cornerstone of mesothelioma treatment for eligible patients. The most common procedures include pleurectomy and decortication, which involve removing the tumor tissue from the pleural lining while sparing the lung, and extrapleural pneumonectomy, a more radical surgery that involves removing the entire affected lung along with the pleura, diaphragm, and pericardium. Surgery is often combined with other therapies to maximize effectiveness. Patient eligibility for surgery depends on factors such as overall health, stage of the disease, and the location of the tumor. Because of the invasive nature of these surgeries, they are typically performed at specialized centers with experience in mesothelioma treatment.
Chemotherapy remains a mainstay in managing mesothelioma, especially for patients who are not candidates for surgery. The standard chemotherapy regimen generally includes pemetrexed combined with cisplatin or carboplatin. These drugs work by targeting rapidly dividing cancer cells, helping to shrink tumors and slow disease progression. Chemotherapy can be administered systemically or directly into the pleural or peritoneal cavity (intracavitary chemotherapy), potentially enhancing local control of the disease. While chemotherapy does not cure mesothelioma, it can extend survival and help manage symptoms such as pain and breathlessness.
Radiation therapy is another modality used to control mesothelioma, either as a primary treatment or adjunct to surgery. It can help reduce tumor size, alleviate symptoms, and treat areas at risk of harboring microscopic disease. Due to the location of mesothelioma and the risk of damaging surrounding healthy tissue, radiation is carefully planned and generally used in combination with surgery or chemotherapy.
Emerging treatments are offering new hope for patients. Immunotherapy, which harnesses the body’s immune system to fight cancer, has shown promising results in clinical trials. Drugs such as immune checkpoint inhibitors (e.g., nivolumab and ipilimumab) are being studied for their ability to improve response rates and survival outcomes. Additionally, targeted therapies aimed at specific genetic mutations and molecular markers are under investigation, offering personalized treatment options in the future.
Palliative care remains an essential component of mesothelioma management, focusing on symptom relief and maintaining quality of life. Supportive treatments like pain management, respiratory therapies, and nutritional support are vital for patients undergoing aggressive treatments or in advanced stages of the disease.
In conclusion, mesothelioma treatment in adults involves a combination of surgery, chemotherapy, radiation, and emerging therapies tailored to the patient’s specific condition. As research continues, the hope is to improve survival rates and quality of life for those facing this formidable disease.